# üöÄ –°–∏—Å—Ç–µ–º–∞ –æ—Ü–µ–Ω–∫–∏ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –∏–¥–µ–π

## üìã –û–ø–∏—Å–∞–Ω–∏–µ

–î–∞–Ω–Ω–∞—è —Å–∏—Å—Ç–µ–º–∞ –ø—Ä–µ–¥–Ω–∞–∑–Ω–∞—á–µ–Ω–∞ –¥–ª—è –æ—Ü–µ–Ω–∫–∏ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –∏–¥–µ–π –Ω–∞ –æ—Å–Ω–æ–≤–µ —Ä—ã–Ω–æ—á–Ω—ã—Ö —Å–∏–≥–Ω–∞–ª–æ–≤, –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å–ø—ã—Ç–∞–Ω–∏–π –∏ –¥—Ä—É–≥–∏—Ö –¥–æ–∫–∞–∑–∞—Ç–µ–ª—å—Å—Ç–≤. –ú–æ–¥–µ–ª—å –∏—Å–ø–æ–ª—å–∑—É–µ—Ç –æ–±–æ–≥–∞—â–µ–Ω–Ω—ã–µ —Ñ–∏—á–∏ –¥–ª—è –ø—Ä–∏–Ω—è—Ç–∏—è —Ä–µ—à–µ–Ω–∏–π –æ –∫–æ–º–º–µ—Ä—á–µ—Å–∫–æ–π –∑–Ω–∞—á–∏–º–æ—Å—Ç–∏ –∏ –≥–æ—Ç–æ–≤–Ω–æ—Å—Ç–∏ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π.

## üéØ –¶–µ–ª–µ–≤—ã–µ –∑–∞–¥–∞—á–∏

1. **–û—Ü–µ–Ω–∫–∞ –∫–æ–º–º–µ—Ä—á–µ—Å–∫–æ–π –∑–Ω–∞—á–∏–º–æ—Å—Ç–∏** - –∞–Ω–∞–ª–∏–∑ —Ä—ã–Ω–æ—á–Ω—ã—Ö —Å–∏–≥–Ω–∞–ª–æ–≤
2. **–û—Ü–µ–Ω–∫–∞ –≥–æ—Ç–æ–≤–Ω–æ—Å—Ç–∏ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π** - –∞–Ω–∞–ª–∏–∑ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å–ø—ã—Ç–∞–Ω–∏–π  
3. **–í–∑–≤–µ—à–∏–≤–∞–Ω–∏–µ –¥–æ–∫–∞–∑–∞—Ç–µ–ª—å—Å—Ç–≤** - —É—á–µ—Ç –Ω–∞–¥–µ–∂–Ω–æ—Å—Ç–∏ –∏—Å—Ç–æ—á–Ω–∏–∫–æ–≤
4. **–ö–ª–∞—Å—Å–∏—Ñ–∏–∫–∞—Ü–∏—è –∏–¥–µ–π** - –æ–ø—Ä–µ–¥–µ–ª–µ–Ω–∏–µ —Ç–∏–ø–∞ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–π –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–∏

## üìä –°—Ç—Ä—É–∫—Ç—É—Ä–∞ –¥–∞—Ç–∞—Å–µ—Ç–∞

### –û—Å–Ω–æ–≤–Ω—ã–µ –∫–æ–º–ø–æ–Ω–µ–Ω—Ç—ã:
- **2,400 —É–Ω–∏–∫–∞–ª—å–Ω—ã—Ö seed –¥–æ–∫—É–º–µ–Ω—Ç–æ–≤** (—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–µ –∏–¥–µ–∏)
- **14,428 items** (–∫–æ–Ω–∫—Ä–µ—Ç–Ω—ã–µ —É—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏—è)
- **24,163 evidence items** —Å –æ–±–æ–≥–∞—â–µ–Ω–Ω—ã–º–∏ —Ñ–∏—á–∞–º–∏

### –¢–∏–ø—ã evidence:
- **Market signals** (4,815) - —Ä—ã–Ω–æ—á–Ω—ã–µ —Å–∏–≥–Ω–∞–ª—ã
- **Clinical trials** (4,886) - –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ –∏—Å–ø—ã—Ç–∞–Ω–∏—è
- **Patents** (4,778) - –ø–∞—Ç–µ–Ω—Ç—ã
- **Papers** (4,769) - –Ω–∞—É—á–Ω—ã–µ —Å—Ç–∞—Ç—å–∏
- **Disclosures** (4,915) - –≤–Ω—É—Ç—Ä–µ–Ω–Ω–∏–µ —Ä–∞—Å–∫—Ä—ã—Ç–∏—è

## üî¨ –ö–ª—é—á–µ–≤—ã–µ —Ñ–∏—á–∏

### 1. –†—ã–Ω–æ—á–Ω—ã–µ —Å–∏–≥–Ω–∞–ª—ã (Market Signals)
```python
{
    "importance_score": 2.74,      # –û–±—â–∞—è –≤–∞–∂–Ω–æ—Å—Ç—å (0-4)
    "type_score": 4.0,             # –¢–∏–ø —Å–æ–±—ã—Ç–∏—è (Product launch=4.0)
    "source_score": 3.0,           # –ù–∞–¥–µ–∂–Ω–æ—Å—Ç—å –∏—Å—Ç–æ—á–Ω–∏–∫–∞ (GlobalDataSim=3.0)
    "type": "Product launch",      # –¢–∏–ø —Å–æ–±—ã—Ç–∏—è
    "source": "GlobalDataSim"      # –ò—Å—Ç–æ—á–Ω–∏–∫ –¥–∞–Ω–Ω—ã—Ö
}
```

**–®–∫–∞–ª–∞ –≤–∞–∂–Ω–æ—Å—Ç–∏:**
- Product launch: 4.0 (–º–∞–∫—Å–∏–º–∞–ª—å–Ω–∞—è –≤–∞–∂–Ω–æ—Å—Ç—å)
- M&A: 3.5
- Partnership: 3.0
- Funding: 2.5
- Market report: 2.0

**–ù–∞–¥–µ–∂–Ω–æ—Å—Ç—å –∏—Å—Ç–æ—á–Ω–∏–∫–æ–≤:**
- GlobalDataSim: 3.0
- DealScope: 2.8
- EvaluateSim: 2.5
- CrunchSim: 2.2
- VentureWatch: 2.0

### 2. –ö–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ –∏—Å–ø—ã—Ç–∞–Ω–∏—è (Clinical Trials)
```python
{
    "maturity_score": 1.68,        # –ó—Ä–µ–ª–æ—Å—Ç—å —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ (0-3)
    "status": "Completed",         # –°—Ç–∞—Ç—É—Å –∏—Å–ø—ã—Ç–∞–Ω–∏—è
    "phase": "Phase 3",           # –§–∞–∑–∞ –∏—Å–ø—ã—Ç–∞–Ω–∏—è
    "status_score": 3.0,          # –ù–æ—Ä–º–∞–ª–∏–∑–æ–≤–∞–Ω–Ω—ã–π —Å—Ç–∞—Ç—É—Å
    "phase_score": 3.0            # –ù–æ—Ä–º–∞–ª–∏–∑–æ–≤–∞–Ω–Ω–∞—è —Ñ–∞–∑–∞
}
```

**–®–∫–∞–ª–∞ –∑—Ä–µ–ª–æ—Å—Ç–∏:**
- Completed + Phase 3: 3.0 (–º–∞–∫—Å–∏–º–∞–ª—å–Ω–∞—è –∑—Ä–µ–ª–æ—Å—Ç—å)
- Active + Phase 2: 2.5
- Recruiting + Phase 1: 2.0
- Terminated: 0.0 (–Ω–∏–∑–∫–∞—è –∑—Ä–µ–ª–æ—Å—Ç—å)

### 3. –¶–µ–ª–µ–≤—ã–µ –∫–ª–∞—Å—Å—ã
- **licensable** (3,071) - –≤—ã—Å–æ–∫–∞—è –∫–æ–º–º–µ—Ä—á–µ—Å–∫–∞—è —Ü–µ–Ω–Ω–æ—Å—Ç—å
- **platform** (3,065) - —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∞—è –ø–ª–∞—Ç—Ñ–æ—Ä–º–∞
- **patentable** (2,954) - –ø–∞—Ç–µ–Ω—Ç–æ—Å–ø–æ—Å–æ–±–Ω–æ—Å—Ç—å
- **freetooperate_flag** (2,938) - —Å–≤–æ–±–æ–¥–∞ –æ–ø–µ—Ä–∞—Ü–∏–π
- **none** (2,400) - –æ—Ç—Ä–∏—Ü–∞—Ç–µ–ª—å–Ω—ã–µ –ø—Ä–∏–º–µ—Ä—ã

## üõ†Ô∏è –ò—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ

### –ü—Ä–∏–º–µ—Ä –æ—Ü–µ–Ω–∫–∏ –∏–¥–µ–∏:
```python
from evaluate_idea_example import evaluate_technology_idea

# –í—Ö–æ–¥–Ω—ã–µ –¥–∞–Ω–Ω—ã–µ
idea_text = "platform architecture with modular cartridges for graphene membranes"
evidence_list = [
    {
        "type": "market",
        "meta": {
            "importance_score": 3.5,
            "type": "Product launch",
            "source": "GlobalDataSim"
        }
    },
    {
        "type": "trial", 
        "meta": {
            "maturity_score": 2.5,
            "status": "Completed",
            "phase": "Phase 3"
        }
    }
]

# –û—Ü–µ–Ω–∫–∞
result = evaluate_technology_idea(idea_text, evidence_list)
print(f"–û–±—â–∏–π —Å–∫–æ—Ä: {result['overall_score']:.2f}/4.0")
```

### –í—ã—Ö–æ–¥–Ω—ã–µ –¥–∞–Ω–Ω—ã–µ:
```python
{
    "scores": {
        "commercial_importance": 3.5,    # –ö–æ–º–º–µ—Ä—á–µ—Å–∫–∞—è –≤–∞–∂–Ω–æ—Å—Ç—å
        "technology_maturity": 2.5,      # –ó—Ä–µ–ª–æ—Å—Ç—å —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π
        "evidence_strength": 0.8,        # –°–∏–ª–∞ –¥–æ–∫–∞–∑–∞—Ç–µ–ª—å—Å—Ç–≤
        "market_activity": 1.0,          # –ê–∫—Ç–∏–≤–Ω–æ—Å—Ç—å —Ä—ã–Ω–∫–∞
        "clinical_progress": 1.0         # –ü—Ä–æ–≥—Ä–µ—Å—Å –≤ –∏—Å–ø—ã—Ç–∞–Ω–∏—è—Ö
    },
    "overall_score": 2.85,              # –û–±—â–∏–π —Å–∫–æ—Ä (0-4)
    "recommendations": [                # –†–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏
        "‚úÖ –í—ã—Å–æ–∫–∞—è –∫–æ–º–º–µ—Ä—á–µ—Å–∫–∞—è –ø—Ä–∏–≤–ª–µ–∫–∞—Ç–µ–ª—å–Ω–æ—Å—Ç—å",
        "‚úÖ –¢–µ—Ö–Ω–æ–ª–æ–≥–∏—è –≥–æ—Ç–æ–≤–∞ –∫ –∫–æ–º–º–µ—Ä—Ü–∏–∞–ª–∏–∑–∞—Ü–∏–∏"
    ]
}
```

## üìà –°—Ç–∞—Ç–∏—Å—Ç–∏–∫–∞ –¥–∞—Ç–∞—Å–µ—Ç–∞

### –†–∞—Å–ø—Ä–µ–¥–µ–ª–µ–Ω–∏–µ —Ñ–∏—á–µ–π:
- **40.1% evidence items** –∏–º–µ—é—Ç –æ–±–æ–≥–∞—â–µ–Ω–Ω—ã–µ —Ñ–∏—á–∏
- **9,701 evidence items** —Å –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–º–∏ –º–µ—Ç—Ä–∏–∫–∞–º–∏
- **–°—Ä–µ–¥–Ω–∏–π importance_score**: 2.74
- **–°—Ä–µ–¥–Ω–∏–π maturity_score**: 1.68

### –ö–æ—Ä—Ä–µ–ª—è—Ü–∏—è —Å –ª–µ–π–±–ª–∞–º–∏:
- **licensable**: 33.96% —Å market evidence, 34.42% —Å trial evidence
- **platform**: 34.81% —Å market evidence, 35.99% —Å trial evidence
- **patentable**: 35.00% —Å market evidence, 35.95% —Å trial evidence

## üéØ –†–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –¥–ª—è –º–æ–¥–µ–ª–∏

### –ü—Ä–∏–æ—Ä–∏—Ç–µ—Ç–Ω—ã–µ —Ñ–∏—á–∏:
1. **importance_score** - —Ä—ã–Ω–æ—á–Ω–∞—è –≤–∞–∂–Ω–æ—Å—Ç—å
2. **maturity_score** - –∑—Ä–µ–ª–æ—Å—Ç—å —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π
3. **type_score** - —Ç–∏–ø —Å–æ–±—ã—Ç–∏—è
4. **source_score** - –Ω–∞–¥–µ–∂–Ω–æ—Å—Ç—å –∏—Å—Ç–æ—á–Ω–∏–∫–∞
5. **evidence_count** - –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –¥–æ–∫–∞–∑–∞—Ç–µ–ª—å—Å—Ç–≤

### –í–µ—Å–∞ –¥–ª—è –∏—Ç–æ–≥–æ–≤–æ–π –æ—Ü–µ–Ω–∫–∏:
- commercial_importance: 30%
- technology_maturity: 30%
- evidence_strength: 20%
- market_activity: 10%
- clinical_progress: 10%

## üìÅ –§–∞–π–ª—ã

- `data/train_final.jsonl` - –æ—Å–Ω–æ–≤–Ω–æ–π –¥–∞—Ç–∞—Å–µ—Ç
- `main.py` - –≥–µ–Ω–µ—Ä–∞—Ü–∏—è –¥–∞—Ç–∞—Å–µ—Ç–∞ —Å —Ñ–∏—á–∞–º–∏
- `analyze_features.py` - –∞–Ω–∞–ª–∏–∑ —Ñ–∏—á–µ–π
- `evaluate_idea_example.py` - –ø—Ä–∏–º–µ—Ä –æ—Ü–µ–Ω–∫–∏ –∏–¥–µ–∏
- `README_EVALUATION.md` - –¥–∞–Ω–Ω–∞—è –¥–æ–∫—É–º–µ–Ω—Ç–∞—Ü–∏—è

## üöÄ –°–ª–µ–¥—É—é—â–∏–µ —à–∞–≥–∏

1. **–û–±—É—á–µ–Ω–∏–µ –º–æ–¥–µ–ª–∏** –Ω–∞ –ø–æ–¥–≥–æ—Ç–æ–≤–ª–µ–Ω–Ω–æ–º –¥–∞—Ç–∞—Å–µ—Ç–µ
2. **–í–∞–ª–∏–¥–∞—Ü–∏—è** –Ω–∞ —Ç–µ—Å—Ç–æ–≤—ã—Ö –¥–∞–Ω–Ω—ã—Ö
3. **–ò–Ω—Ç–µ–≥—Ä–∞—Ü–∏—è** –≤ —Å–∏—Å—Ç–µ–º—É –æ—Ü–µ–Ω–∫–∏ –∏–¥–µ–π
4. **–ú–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥** –∫–∞—á–µ—Å—Ç–≤–∞ –ø—Ä–µ–¥—Å–∫–∞–∑–∞–Ω–∏–π
5. **–ò—Ç–µ—Ä–∞—Ç–∏–≤–Ω–æ–µ —É–ª—É—á—à–µ–Ω–∏–µ** –Ω–∞ –æ—Å–Ω–æ–≤–µ –æ–±—Ä–∞—Ç–Ω–æ–π —Å–≤—è–∑–∏
